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The Great Lakes basin is characterized as a heavily populated and industrialized region in which a
large number of environmental contaminants have been identified. Both the scientific community
and the public have voiced concern that contaminants present in the Great Lakes may pose
undue risk to human reproduction. Evidence from animal experiments, wildlife studies, and
reports of occupational and accidental human exposures indicate that chemical contaminants can
adversely affect reproduction. The purpose of this paper is to review the reproductive toxicity of
some of the many contaminants known to be present in the Great Lakes. Since the number of
chemicals present in the Great Lakes is far too great for each to be adequately reviewed here,
discussion will be limited to those contaminants that have been identified in human serum, ovarian
follicular fluid, and semen obtained from people residing in the Great Lakes region. It is concluded
that a) the data at present is too limited to support the notion that reproduction, in the general
population, has been impaired by exposure to chemicals present in the Great Lakes; b) the lack of
data in some cases such as for hexachloroethane and 1,2,4-trichlobenzene does provide reason
for concern and underscores the need for further research in this area; and c) the potential for a
number of the compounds, including polychlorinated biphenyls (PCBs) and 1,1,1-trichloro-2,2-bis(p-
chlorophenyl) ethane (DDT), to disrupt endocrine functions suggests that additive or synergistic
effects of these compounds may already be causing adverse effects on reproduction in sensitive
individuals, which needs to be explored. - Environ Health Perspect 103(Suppl 9):63-69 (1995)
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Introduction
Waters ofthe Great Lakes provide a source
for drinking water, recreation, and food
for many North Americans. The Great
Lakes have become contaminated with a
vast array of chemical contaminants. The
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reproductive consequences of human
exposure to these contaminants are largely
unknown. However, serious effects on
reproduction have been shown in epidemi-
ologic studies describing occupational expo-
sure to high concentrations of chemicals
(1-6) and also in wildlife populations
exposed to environmental pollutants (7).
The publication of these data and the
media attention given to the potential for
human exposure to environmental chemi-
cals have made the public anxious about
the potential reproductive hazards posed by
these compounds. However, the question
ofwhether contaminants present in the
Great Lakes pose undue risk to human
reproduction remains unanswered.
This paper addresses the question of
whether environmental contaminants in
the Great Lakes affect human reproduc-
tion. Reproductive hazards will be consid-
ered to be any hazard that interferes with
production ofnormal gametes, conception,
and in utero development. For the purposes
ofthis review, discussion will be limited to
those chemicals that have been identified
in the serum, ovarian follicular fluid, or
semen of people residing in the Great
Lakes basin. Specifically, the reproductive
toxicity data ofcontaminants that are pre-
sent in a large percentage ofthe population,
such as hexachlorobenzene (HCB), 1,1,1-
trichloro-2,2-bis(p-chlorophenyl)ethane
(DDT), 1,1-dichloro-2,2-bis(p-chloro-
phenyl)ethane (DDD), and 1,1-dichloro-
2,2-bis(p-chlorophenyl)ethylene (DDE),
or are present in concentrations that are
sufficiendy high to warrant concern, includ-
ing polychlorinated biphenyls (PCBs) and
chlorinated dibenzo-p-dioxin (CDD),
brominated dibenzo-p-dioxin (BDD), and
chlorinated dibenzofurans (CDFs), will be
described briefly. The mechanisms oftoxic-
ity ofthese contaminants are beyond the
scope ofthis review and therefore will not
be included. Furthermore, the reproductive
toxicity ofmany ofthese contaminants has
been reviewed in detail elsewhere. Conse-
quently, the principal effects of these con-
taminants on reproduction and the dose or
body burden associated with these effects
will be briefly discussed.
Contaminants and Residue
Levels Identified in Human
Serum, Ovarian Follicular
Fluid, and Semen
Estimating or, better still, measuring expo-
sure to reproductive toxicants is essential.
Without exposure estimation, a predicted
dose cannot be calculated, and the risk to a
specific reproductive outcome cannot be
characterized or given a probabilistic value.
There are a number ofreports (8-25) from
different regions of the world describing
trace levels of numerous contaminants
found in human serum, breast milk, fat,
ovarian follicular fluid, and seminal plasma.
The body burdens of a limited number of
contaminants from Ontario residents have
also been reported (10,17,25). Mean
residue levels in the serum, fat, and ovarian
follicular fluid of ox-chlordane (ALCH),
DDE, DDT, heptachlor-epoxide-oxy-
chlordane (OXCH), HCB, total PCBs,
and dieldrin for Ontario women (10,25)
are summarized in Table 1. In a recent
study (25), the body burdens of a number
of Great Lakes chemicals in the serum and
ovarian follicular fluid ofwomen residing
in Hamilton, Ontario were compared with
levels found in women from Halifax and
Vancouver. Regional differences were
observed, with women from Halifax having
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Table 1. The mean ± SD residue concentrations (ppb) of ALCH, DDE, OXCH, HCB, PCB, DDT, and dieldrin in the
serum, ovarian follicular fluid, and fat of Ontario women.
Contaminant Serum % ND Follicularfluid % ND Fat
ALCH 0.29 ± 0.31 38 0.30 ± 0.30 52
DDE 1.04 ± 0.57 0 0.73 ± 0.40 0
OXCH 0.29 ± 0.22 48 0.27 ± 0.25 55
HCB 0.21 ±0.09 10 0.14± 0.08 28
PCB 3.68 ±4.10 38 4.08 ±5.68 55
DDT 4.66 ±3.20
Dieldrin 0.04± 0.03
ND, percentage of samples with residue levels below the level of detection. Data from Jarrell et al. (25) and
Frank et al. (17).
the lowest frequency and level ofcontami-
nation. However, no differences in the rate
ofoocyte cleavage or time to cleavage ofthe
first egg were found between those with
high contaminant levels and those with low
levels. In a separate ongoing study, residue
levels of46 PCB congeners and 36 chlori-
nated contaminants were measured in the
serum and ovarian follicular fluid from 25
women undergoing ovulation induction in
each ofthree Ontario fertility clinics (WG
Foster, unpublished data). The study design
and methods employed were analogous to
those of an earlier study (25), with the
exception that the male counterpart ofthe
couple was included in one ofthe centers
and more contaminants were included in
screening. Briefly, samples were extracted
with hexane and analyzed by means ofgas
chromatography-mass spectroscopy.
Residue quantification was based on detec-
tion of the primary ion for each contami-
nant of interest. Detection limits varied
with the contaminant and ranged from
100 to 300 parts per trillion (ppt) for
organochlorine pesticides and from 12.5 to
100 ppt for PCBs. While the majority of
contaminants were below the level of
detection in the sampled tissues, a few
chemicals were found in a high percentage
ofsubjects. The frequency ofdetection and
residue levels ofhexachloroethane (HCE),
1,2,4-trichlorobenzene (TCB), DDE, and
PCB congeners 153, 138, and 180 are
summarized in Table 2.
Reproductive Toxicity of
Contaminants Present
in Human lissues
HCB
Hexachlorobenzene was introduced in the
1940s as a seed grain antifungal, and its use
in North America was discontinued by
mid-1970s. Nevertheless, HCB continues
to be produced in large quantities as a by-
product in the manufacture ofchlorinated
solvents and also exists as an impurity of
several pesticides (26). Thus, HCB contin-
ues to pose a risk to human health due to
its continued entry into the environment,
resistance to degradation, and a propensity
to bioaccumulate.
Interest in the toxicity of HCB began
with an outbreak ofcutaneous porphyria in
Turkey in 1956 in people who had con-
sumed HCB-tainted wheat (27). Since
then, the hepatotoxic and immunotoxic
effects ofHCB have been well documented.
In contrast, the reproductive effects of
HCB have received comparatively less
attention, and there are no reports ofdevel-
opmental or reproductive effects ofHCB in
exposed humans.
Data from animal experiments reveal
that HCB is both a developmental and
reproductive toxicant. HCB has been
shown to cross the placenta to the develop-
ing conceptus in mice, rats, and rabbits
(28-30). Exposure ofpregnant rats to doses
up to 120 mg/kg/day failed to induce any
adverse effects on organogenesis (31). In
multigenerational studies, HCB exposure at
doses as low as 2 mg/kg/day induced
increased liver weights and decreased body
weights ofpups ofboth sexes (32,33). Pup
viability (33) and lactational index (32)
were also decreased at higher doses (8
mg/kg/day). Developmental effects ofthe
skin, bone and nervous system have been
described in children accidentally exposed
to HCB before attaining puberty (34,35).
Unfortunately, there is no exposure data to
aid in the dose-response characterization
for these effects, and no animal studies
have been undertaken to explore the mech-
anism for these effects.
Data relating to the treatment ofadult
female animals with HCB suggest that this
compound is primarily an ovarian toxicant.
This conclusion is supported by the demon-
stration ofaltered steroidogenesis in the rhe-
sus monkey in the absence ofchanges in
circulating levels ofpituitary gonadotropins
(36). Altered ovarian steroidogenesis has
also been shown in both the cynomolgus
monkey (37) and the rat (38). In a recent
study (39), HCB treatment (10 mg/kg/day
for 90 days) resulted in depressed ovulatory
levels ofestradiol and response to ovulation
induction in the cynomolgus monkey.
Furthermore, degenerative changes in pri-
mordial follicles and the ovarian germinal
epithelium have been demonstrated in
cynomolgus monkeys (40,41) with HCB
treatment at levels as low as 0.1 mg/kg/day,
which suggests that ovarian function may
also be altered at levels lower than previ-
ously reported. Ultrastructural changes in
the ovary appear to be the most sensitive
end point, and these occur with HCB
treatment at a dose of 0.1 mg/kg/day for
90 days (41). It is important to note that a
no observable adverse effect level
(NOAEL) has not yet been established for
this compound using this end point.
Treatment at this dose level resulted in
serum levels of 27± 9 parts per billion
(ppb) (39) compared to 0.21 ppb for the
human population (25). Since a NOAEL
has yet to be established and adverse
effects occur at levels two orders ofmagni-
tude greater than the serum levels mea-
sured in the human population, it is
suggested that HCB represents a concern
to ovarian function.
Morphometric studies in which ovarian
follicle numbers have been shown to be
significantly reduced following exposure to
Table 2. The mean ± SD residue concentrations (ppt) of HCE, TCB, DDE, Mirex, and the PCB isomers 153, 138, and
180 in the serum(n=75), ovarian follicularfluid, (n=75), and semen (n=25) of Ontario residents.
Contaminant Serum % ND Follicularfluid % ND Semen % ND
HCE 80a 99.99 217.86 ± 167.52 52 80a 99.99
TCB 389.31 ± 285.25 35 230.42 ± 162.39 0 80a 99.99
DDE 3279.6 ± 13753.36 8 2289.53 ± 4096.22 55 392.67 ± 430.23 70
Mirex 632.23± 1602.58 17 1474.58 ± 2273.78 28 100.89 ±83.66 44
PCB-153 156.45 ± 141.38 20 282.01 ± 290.30 55 100
PCB-138 133.32 ± 135.42 36 124.44 ± 120.77 31 100
PCB-180 87.46± 83.34 40 99.05± 65.44 33 100
ND, percentage of samples with residue levels belowthe level of detection. aSingle positive sample only.
Environmental Health Perspectives L Vol 103, Supplement 9 * December 1995 64GREAT LAKES CONTAMINANTS AND REPRODUCTION
reproductive toxins such as 7,12-dimethyl-
benz[a]anthracene, benzo[a]pyrene, 2,5-
hexanedione, and hexachlorobenzene
(42-46) suggest that HCB and these
agents may induce premature ovarian fail-
ure. This hypothesis is supported by the
observation of a biexponential decline in
ovarian follicle numbers for the human
ovary (47). According to this model, ovar-
ian follicles decline at one rate until approx-
imately 37.5 years of age, after which the
rate of ovarian aging more than doubles
until the follicle population is reduced to
about 1000 follicles at the age ofaround 51
years. Since ovarian failure and menopause
are triggered by the number of follicles
falling below a threshold level, these data
suggest that environmental contaminants
such as HCB have the potential ofadvanc-
ing the age of ovarian failure and thus
menopause onset.
HCE
Hexachloroethane is a compound that is
used as an inhibitor in explosives, in the
manufacture ofsmoke candles andgrenades,
as a rubber vulcanizing accelerator, and in
metal refining. Human exposure is most
likely to occur through inhalation or as a
result of drinking contaminated water.
However, there is virtually no literature
describing the developmental or reproduc-
tive toxicity ofthis compound. In a single
report (48), Sprague-Dawley rats were
treated from day 6 to day 16 ofgestation
either by inhalation (15, 48, or 260 ppm
for 6 hr/day) or gavage (50, 100, and 500
mg/kg/day). At the highest dose, the num-
ber offetal resorptions were increased and
the number of live fetuses per litter were
decreased. No evidence ofstructural effects
were found. There are no reports ofrepro-
ductive effects of HCE treatment in adult
animals ofeither sex. Thus, in the absence
ofdata, it is not possible to conclude what
risk ifany this compound poses to human
reproduction. This is a concern since HCE
has been identified in the ovarian follicular
fluid in 48% ofwomen from three fertility
clinics in Ontario (WG Foster, unpub-
lished data). Therefore, there is a need to
examine the effect of HCE on follicle
selection, growth, differentiation, ovula-
tion and atresia. In addition, the effect of
HCE on sperm egg interactions should
also be explored.
TCB
1,2,4-Trichlorobenzene has found applica-
tion as a solvent in chemical manufacturing,
dielectric fluid, and synthetic transformer
oils and lubricants. It is also used as a heat
transfer medium. Human exposure to this
compound is likely through drinking con-
taminated water or consumption ofconta-
minated fish.
Like HCE, there is very little data
relating to TCB effects on reproduction. At
doses less than 300 mg/kg in the rat, there
does not appear to be any effect upon fertil-
ity, growth, or viability of the conceptus
(49-51). At higher doses ofTCB (360
mg/kg/day during days 9-13 ofgestation)
in the rat, embryonic growth was reduced
(51). Interestingly, ip injection ofTCB (0,
250, and 500 mg/kg) on 3 consecutive days
induced a decrease in the rat uterine weight
indicating an antiestrogenic effect (49).
TCB was frequently identified in the
serum (65% ofall samples) and in all sam-
ples of ovarian follicular fluid ofwomen
participating in fertility programs in three
Ontario cities (Table 2). In contrast, TCB
was found in the semen ofonly one patient
in the study. Although levels present in the
serum and ovarian follicular fluid are low
and the levels at which effects have been
seen in the rat are high, it seems unlikely
that TCB poses a serious concern to human
reproduction. However, the potential anti-
estrogenic effects ofthis compound need to
be confirmed and the mechanism explored.
Furthermore, given the frequency of
identification ofTCB in the serum and
ovarian follicular fluid, the potential for
additive and synergistic effects with com-
pounds such as dioxin, dibenzofurans, and
PCB congeners needs to be explored.
DDT, DDD, andDDE
DDT is a well-known pesticide formerly
widely used to control insects on agricul-
tural crops. It has also been used to control
head lice and to kill insects carrying diseases
such as typhus and malaria. Both DDD
and DDE were present as contaminants in
commercial formulations ofDDT, and the
presence ofDDE in the environment is pri-
marily the consequence of the breakdown
of DDT. The developmental and repro-
ductive toxicity of these compounds has
been well documented, and they are the
subject of a recent Agency for Toxic
Substances and Disease Registry (ATSDR)
update (52). Therefore, the reproductive
toxicity ofthis group ofcontaminants will
not be reviewed in detail here.
There are no studies that establish an
association between adverse reproductive
outcomes in humans with circulating levels
ofDDT, DDD, or DDE. In animal experi-
ments these compounds have been shown
to be embryotoxic and fetoxic in the
rodent (53), but they are not known to be
teratogenic. Effects in the adult are the
consequence ofhigh doses while fetal effects
are observed at much lower levels. Adverse
effects ofDDT treatment on fertility have
been shown in the rat and in beagle dogs
treated with DDT (0.35-39 mg/kg/day)
(54,55). A number oflines ofevidence sug-
gest that the adverse effects of DDT and
related compounds may be mediated
trough their structural similarity to estro-
gen and, thus, interaction with the estro-
gen receptor. In particular, exposed rats
have been induced to enter precocious
puberty (56); in adult female rats, uterine
weight has been increased by treatment
with DDT, and RNA or DNA and carbo-
hydrate contentwas also increased (57-59).
In the immature rat uterine glycogen con-
tent assay, o,p'-DDT was found to be the
most active ofthis family ofenvironmental
pollutants (57). In contrast, DDE was 16
times less active than o,p'-DDT, which was
equivalent to phenolphthalein, a com-
pound used in laxative preparations. The
relative potency of o,p'-DDT was 1/1.0 x
106 compared to estradiol in the MCF-7
cell proliferation assay (60). Although, these
contaminants are weak estrogens compared
to estradiol they represent a serious concern
to human reproduction because they persist
in the body at physiologically relevant con-
centrations, they can interact with the estro-
gen receptor and induce estrogen responses
in sensitive tissues, and, unlike endoge-
nous estrogens, they are not bound to sex
hormone binding globulin. Thus, the
potential for these compounds to adversely
affect human reproduction needs to be
carefully investigated.
PCBs
Polychlorinated biphenyls are members of
a large family ofwidely used chemicals that
have become ubiquitous environmental
contaminants. Commercial production of
PCBs commenced in 1929 in the United
States, and the resulting products were
marketed according to their chlorine con-
tent (Aroclor 1221, 1252, and 1260, for
example). The last two digits in the PCBs
number refers to the percentage ofchlorine
present in the mixture based on the wet
weight. Commercial PCBs are mixtures of
a large family of 209 specific congeners.
They have been used in a wide variety of
applications including plasticizers, pesticide
extenders, adhesives, cutting oils, and flame
retardants. They are perhaps best known for
their use in heat transferfluids anddielectric
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fluids for transformers and capacitors.
PCBs are very stable compounds that resist
degradation and are lipophilic; thus they
bioaccumulate in the food chain. They
were first identified as a potential environ-
mental hazard in 1966 byJensen (61) and
were subsequently shown to cause com-
plete reproductive failure in mink (62).
Levels ofPCBs present in the whole blood
of Canadians living in Great Lakes com-
munities range from 6.2 ± 4.2 to 13.0 ±
9.9 ppm (63). The reproductive and devel-
opmental effects of PCBs have been well
documented and the reader is referred to
recent reviews for further details (64-66).
In adult animals (mice, rats, and mon-
keys) treated with PCBs (Clophen A-60 or
Aroclor 1254), there is evidence ofincreased
estrous/menstrual cycle lengths (36,67,68)
and evidence ofanovulation in the monkeys
(36). Effects ofPCBs on the estrous cycle,
however, have not been found in another
study in rats treated with Aroclor 1242 (3.7
or 7.5 mg/kg/day for 36 weeks). Changes
in circulating levels ofovarian steroids have
been documented (36,55) at PCB treat-
ment levels as low as 7.5 mg/kg/day for 36
weeks. Reduction of the number offertil-
ized ova that implant has also been
reported (67). Moreover, PCB treatment
has also been shown to induce a reduction
in the number ofovarian follicles (67), thus
suggesting that prolonged exposure could
induced premature ovarian failure in sensi-
tive individuals. In adult males treated with
PCB, reduced sperm counts have also been
documented. In one study, levels of32 PCB
congeners were measured (69), and 3 were
inversely correlated with semen quality in
samples with sperm counts below 20x106.
It has been proposed that, due to the
structural similarities of some of the PCB
congeners (the non-ortho substituted con-
geners: 3,3',4,4'-tetrachlorobiphenyl,
3,3',4,4',5'-pentachlorobiphenyl, and
3,3',4,4',5,5'-hexachlorobiphenyl) with
TCDD, a common mechanism is fol-
lowed. Specifically, it is believed that some
PCB congeners interact with the aryl
hydrocarbon receptor and are translocated
into the cell nucleus and interact with
dioxin response elements. However, other
PCB congeners such as PCB 153 bear no
structural resemblance to TCDD and,
in'deed in contrast to TCDD, act like an
estrogen rather than an antiestrogen. Lightly
chlorinated PCB mixtures with less than
48% chlorine content (Aroclor 1248, 1242,
etc.) have been shown to be estrogenic,
while the heavily chlorinated PCB mixtures
such as Aroclor 1254, 1260, 1262, 1268,
and 4465 are inactive in the immature rat
uterine glycogen content assay (57). In
neonatal rats treated with a PCB mixture
containing 21% chlorination (Aroclor
1221), precocious puberty, persistent vagi-
nal estrus, and premature reproductive
senescence was induced (70). The role of
estrogens in the development ofthe sexual
organs and behavior has been well estab-
lished. The consequences of exposure to
compounds with estrogenic activity can
include feminization of the male, develop-
mental abnormalities of the reproductive
tract, decreased semen quality, and prema-
ture sexual maturation. While estrogenic
effects of environmental pollutants have
been blamed for developmental abnormali-
ties in wildlife species (7), there have not
been any reports ofadverse effects following
low-level exposure to estrogenic compounds
in the human population. However, the
majority of these compounds have been
shown to be very weak estrogens (60).
Information concerning the bioavailability
and metabolic fate ofestrogenic compounds
is sparse. Differences in receptor affinity
and the sensitivity ofthe estrogenic target
systems in humans to these compounds
need to be evaluated. Thus, at present the
link between exposure to estrogenic com-
pounds such as PCBs, DDE, and DDT
and adverse reproductive outcomes cannot
be established with confidence. Regardless,
sufficient evidence exists to suggest that this
area should be a priority for future research.
CDD, BDD, andCDF
2,3,7,8-Tetrachlorodibenzo-p-dioxin
(TCDD) is generally considered to be the
most toxic isomer ofthe 75 possible CDD
congeners. Moreover, TCDD is also
regarded as the most potent ofthe CDDs,
BDDs, and CDFs and thus serves as the
model congener for discussion ofthe devel-
opment and reproductive toxicity of this
chemical class. These compounds occur in
the environment at relatively low levels but
have been shown to be toxicologically
significant environmental contaminants.
They are not manufactured commercially
but occur through the combustion of
industrial and municipal waste, as well as
through burning automotive fuels contain-
ing chlorinated additives. They are also
present as contaminants in some herbicides
and fungicides. An additional route of
entry into the environment results from
forest fires. Contemporary residue levels of
TCDD in human tissues obtained from
people riding in the Great Lakes region
are sparse and are not different from those
of the general population. Patterson et al.
(71) have measured TCDD levels in a
large number ofhuman adipose and serum
samples from the United States. Levels
were between 3 and 10 pg/g oflipid. The
development and reproductive toxicity of
dioxins and related compounds have been
reviewed previously (72) and thus will not
be covered extensively here.
Postnatal effects in the male have been
shown to include altered androgenic status
in the male rat (73), which may be respon-
sible for decreases in testis and epididymal
weights and decreased number ofsperm in
the cauda epididymis. Alterations in andro-
gen production reported by Mably et al.
(73) have not been reproduced by others
using the same protocol in another strain
of rat (74,75). The most sensitive end
point measured so far is the number of
sperm in the cauda epididymis. It is impor-
tant to note that there is essentially no
threshold for this effect, with adverse
effects seen as low as 0.016 pg/kg adminis-
tered once to the dam during gestation.
These effects occur in the absence of
changes to body weight. Although effects
were shown on the number ofsperm pre-
sent in the cauda epididymis, evidence of
decreased sperm quality have not been
determined. Furthermore, no meaningful
changes have been observed in fertility
index or gestational index oftreated males.
The number of sperm in the cauda epi-
didymis is a poor marker ofreproductive
effects since the number of sperm in the
cauda epididymis depends on the time
from the last ejaculation. Thus, using this
as a sensitive end point will cause problems
with interpretation. Moreover, further
research will be required to more fully
characterize the mechanism of action of
TCDD on spermatogenesis.
There are very few data describing the
effect ofdioxin exposure in the adult female,
and the literature to date is equivocal.
Effects on female reproduction included
reduced fertility, decreased litter size,
gonadal effects, and changes in estrous/men-
strual cycle characteristics. In the rodent,
chronic exposure to TCDD (0.1 plg/kg/day)
resulted in altered fertility and was
significant at a lower dose (0.01 pg/kg/day)
in the F1 generation than in the Fo (76).
Anovulation and ovarian dysfunction were
shown in rats treated with 1 to 2 pg/kg/day
TCDD for 13 weeks (77). In contrast to
these findings, Kociba and co-workers (77)
were unable to demonstrate any effects on
the female reproductive system in a 2-year
study using dioxin doses of 0.001 and
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0.01 pg/kg/day. In rhesus monkeys, effects
on reproductive function have been associ-
ated with chronic exposure to 50 and 500
ppt TCDD in the diet. However, chronic
treatment with lower levels ofTCDD (5
and 25 ppt) have not produced any
adverse effects on reproduction (78,79).
Therefore, effects on female reproductive
physiology in the rodent may be limited to
chronic exposure to relatively high levels
of TCDD.
In a recent report (80), it has been
demonstrated that chronic exposure of
rhesus monkeys to 5 and 25 ppt TCDD in
the diet for 4 years induced a dose-depen-
dent increase in the prevalence and sever-
ity of endometriosis when evaluated 10
years after the initiation of the study. The
role ofTCDD in the pathophysiology of
human endometriosis is far from clear.
Since TCDD is an antiestrogen, it would
be expected to inhibit the progress of
endometriosis, which is an estrogen-depen-
dent disease. Alternatively, it is also possi-
ble that the immunosuppressant effects of
TCDD may facilitate the development of
endometriosis. There are a number ofepi-
demiologic studies currently in progress,
and this will remain an area of research
priority for the near future.
Summary and Conclusion
Residue levels ofa number ofenvironmental
pollutants present in the Great Lakes have
been identified in human tissues, and the
reproductive toxicity ofsome ofthese were
reviewed in this paper. In general, there is no
evidence that, for the compounds reviewed
and at the levels present in tissues ofpeople
residing in the Great Lakes region, adverse
reproductive outcomes have occurred.
Nevertheless, on the basis ofanimal experi-
ments, it is concluded that these com-
pounds possess the potential to affect
human development and reproduction,
although a link between exposure and
adverse effects has yet to be shown.
Concern continues to exist due to the lack
of data for HCE and TCB, the potential
for developmental effects due to TCDD at
levels that are relevant to the human popu-
lation, and the potential for contaminants
such as DDT, DDD, DDE, and PCBs to
disrupt endocrine function. Consequently,
there is a need for studies ofthe action of
these compounds in mixtures. Although
the individual estrogenic potencies of
DDT, DDD, DDE, and PCBs are rela-
tively low compared to estradiol, the addi-
tive and synergistic effects of these
compounds need to be explored.
The majority of data regarding male
reproductive toxicity has been derived from
rodent studies. These rodent studies are rel-
atively insensitive to the effects ofreproduc-
tive toxicants on fertility, as rodents have
relatively high sperm counts and fecundity
and thus a good fertility reserve. Evaluation
ofspermatogenesis and semen quality in
the rodent are much more sensitive end
points ofreproductive effects ofdrugs and
chemical contaminants. In a number of
reports (81-85), it has been demonstrated
that it is possible to detect moderate to
severe sperm damage in rodents following
acute exposure to suspected reproductive
toxicants. Semen quality and testicular his-
tomorphology with tubular staging can also
serve as useful biomarkers.
We conclude that there is no evidence
to establish a link between chronic low-
level environmental chemical exposure and
adverse reproductive effects in the human
population in the Great Lakes. However,
identification of chemical pollutants in
human tissues raises concern but does not
constitute an effect on reproduction and
the conceptus. It is essential that more sen-
sitive and relevant end points ofreproduc-
tive toxicity be used to generate a more
complete database.
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